Breast Cancer (ASCO Conference News)

Study Finds No Difference in Prognosis for Young Patients

Published in Women's Health Weekly, June 1st, 1998

Results of a new study show that young women with early-onset breast cancer who have a BRCA mutation have the same outcome as women without a mutation.

Prognosis was the same for both groups, even though the BRCA-associated tumors were more likely to manifest aggressive features.

Researchers Mark E. Robson, MD, et al. at Memorial Sloan-Kettering Cancer Center in New York reviewed the clinical records of 91 Ashkenazi Jewish women who were diagnosed with breast cancer at or before age 42. They found that one-third of the women had a BRCA1 or BRCA2 mutation.

Though BRCA-associated tumors appeared more aggressive when examined...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1998-06-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry